Juqiang H. Han

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Fibroblast growth enhancement and antibiotic-free disinfection via microneedles with self-powered electrical stimulations.

Fibroblast growth enhancement and antibiotic-free disinfection via microneedles with self-powered electrical stimulations.

Journal: Nanoscale
Published: February 18, 2026

Rapid detection of Burkholderia cepacia complex carrying the 16S rRNA gene in clinical specimens by recombinase-aided amplification.

Rapid detection of Burkholderia cepacia complex carrying the 16S rRNA gene in clinical specimens by recombinase-aided amplification.

Journal: Frontiers in cellular and infection microbiology
Published: July 01, 2022

Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Journal: Therapeutic advances in gastroenterology
Published: March 11, 2022

A Recombinase Aided Amplification Assay for Rapid Detection of the Klebsiella pneumoniae Carbapenemase Gene and Its Characteristics in Klebsiella pneumoniae.

A Recombinase Aided Amplification Assay for Rapid Detection of the Klebsiella pneumoniae Carbapenemase Gene and Its Characteristics in Klebsiella pneumoniae.

Journal: Frontiers in cellular and infection microbiology
Published: July 23, 2021

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis.

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: April 22, 2021

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease.

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease.

Journal: Frontiers in medicine
Published: January 14, 2021

LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.

LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.

Journal: Hepatology (Baltimore, Md.)
Published: November 06, 2020

Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study.

Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study.

Journal: The Lancet regional health. Western Pacific
Published: August 26, 2020

Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.

Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.

Journal: Cancer science
Published: December 12, 2019

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Journal: Cell metabolism
Published: December 05, 2019

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Journal: Cell metabolism
Published: April 12, 2019

Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.

Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.

Journal: Medicine
Published: August 17, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026